Peter Strumph

Peter Strumph

Company: Parvus Therapeutics

Job title: ceo

Seminars:

Tackling Tissue Specificity: The Translational Journey from Antigen Selection to Clinical Proof-of-Concept 1:45 pm

Selecting the antigen of choice for delivery/presentation with MHCII Highlighting data showing tissue specificity, bystander effect, disease modification, and persistence Discussing plans for clinical proof-of-concept for direct measurement of endogenously expanded Treg cellsRead more

day: Conference Day Two

ABOUT US

Hanson Wade specializes in scientific research across a comprehensive range of distinctive R&D areas. We deliver insight and connections to facilitate safe and effective drug development for more personalized and targeted patient populations.

EXPLORE OUR PRODUCTS

Conferences Beacon
Searchlight Intelligence

OUR CONTACT DETAILS

Phone
UK: +44 (0)20 3141 8700
US: +1 617 455 4188

Email
info@hansonwade.com

JOIN OUR TEAM

We are always looking for ambitious people to join our team. You'll have opportunities to learn quickly, advance your career, and to meaningfully impact our customers and our business.

Click here to learn about careers.

SEARCH

ORGANIZED BY

Terms & Conditions

Privacy Policy

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.